These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2926171)

  • 21. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of cysts in the heart and brain of mice inoculated with avirulent toxoplasmas].
    Thiermann E; Arribada A
    Rev Med Chil; 1974 Feb; 102(2):98-103. PubMed ID: 4157426
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mechanism of the persistence of a less virulent strain of Toxoplasma gondii in the body of the host].
    Savina MA
    Parazitologiia; 1981; 15(5):430-5. PubMed ID: 7290737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chicken line-dependent mortality after experimental infection with three type IIxIII recombinant Toxoplasma gondii clones.
    Schares G; Herrmann DC; Maksimov P; Matzkeit B; Conraths FJ; Moré G; Preisinger R; Weigend S
    Exp Parasitol; 2017 Sep; 180():101-111. PubMed ID: 27913108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice.
    Araujo FG; Slifer T
    Infect Immun; 2003 Jul; 71(7):4171-4. PubMed ID: 12819111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of Toxoplasma gondii on animal behavior: playing cat and mouse.
    Webster JP
    Schizophr Bull; 2007 May; 33(3):752-6. PubMed ID: 17218613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of a virulence mutant uncovers the ribosome biogenesis regulatory protein of Toxoplasma gondii.
    Milligan-Myhre KC; Rooney PJ; Knoll LJ
    J Parasitol; 2011 Dec; 97(6):1173-7. PubMed ID: 21736491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Toxoplasma gondii infection in grey seals (Halichoerus grypus).
    Gajadhar AA; Measures L; Forbes LB; Kapel C; Dubey JP
    J Parasitol; 2004 Apr; 90(2):255-9. PubMed ID: 15165046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of parasite burdens in blood and tissues during murine toxoplasmosis.
    Djurković-Djaković O; Djokić V; Vujanić M; Zivković T; Bobić B; Nikolić A; Slavić K; Klun I; Ivović V
    Exp Parasitol; 2012 Jul; 131(3):372-6. PubMed ID: 22613495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR.
    Luo W; Aosai F; Ueda M; Yamashita K; Shimizu K; Sekiya S; Yano A
    J Parasitol; 1997 Dec; 83(6):1070-4. PubMed ID: 9406781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
    Suzuki Y; Conley FK; Remington JS
    J Immunol; 1989 Sep; 143(6):2045-50. PubMed ID: 2506275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts.
    Chew WK; Wah MJ; Ambu S; Segarra I
    Exp Parasitol; 2012 Jan; 130(1):22-5. PubMed ID: 22027550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of Toxoplasma gondii bradyzoite expressing the green fluorescent protein.
    Nishikawa Y; Zhang H; Ibrahim HM; Ui F; Ogiso A; Xuan X
    Parasitol Int; 2008 Jun; 57(2):219-22. PubMed ID: 18006371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii.
    Villegas EN; Elloso MM; Reichmann G; Peach R; Hunter CA
    J Immunol; 1999 Sep; 163(6):3344-53. PubMed ID: 10477604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Toxoplasma gondii mutant defective in responding to calcium fluxes shows reduced in vivo pathogenicity.
    Lavine MD; Knoll LJ; Rooney PJ; Arrizabalaga G
    Mol Biochem Parasitol; 2007 Oct; 155(2):113-22. PubMed ID: 17643508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasma gondii virulence: changing pattern under different maintenance conditions.
    Olliaro P; Marchetti A; Regazzetti A; Fabbi M; Gorini G
    Parassitologia; 1993 Dec; 35(1-3):17-9. PubMed ID: 8065815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mic1-3KO tachyzoite a live attenuated vaccine candidate against toxoplasmosis derived from a type I strain shows features of type II strain.
    Moiré N; Dion S; Lebrun M; Dubremetz JF; Dimier-Poisson I
    Exp Parasitol; 2009 Oct; 123(2):111-7. PubMed ID: 19508866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxoplasma gondii: differential protection rates by two strains against cyst formation in a rat model.
    Freyre A; Falcón J; Mendez J; González M
    Exp Parasitol; 2006 Dec; 114(4):265-70. PubMed ID: 16709408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new atypical highly mouse virulent Toxoplasma gondii genotype isolated from a wild black bear in Alaska.
    Dubey JP; Rajendran C; Ferreira LR; Kwok OC; Sinnett D; Majumdar D; Su C
    J Parasitol; 2010 Aug; 96(4):713-6. PubMed ID: 20486739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.